ÇÐÀ§³í¹®

µµ¼­°ü¼­ºñ½º

 

 

ÇÐÀ§³í¹®

 

 "Á¤½Å°Ç°­ÀÇÇÐÀü°ø" (À¸)·Î °Ë»öÇÑ °á°ú

S-adenosyl-1-methionineÀÇ ¿ì¿ïÁõ Ä¡·áÈ¿°ú

Antidepressant Effects of S-Adenosyl-L-Methionine in Depressed Patients TS

ÀúÀÚ : ¹ÚÇü¹è

Àü°ø : Á¤½ÅÀÇÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1988  

ºÒ¾È-¿ì¿ï ÅëÇÕôµµÀÇ ÀÓ»óÀû Àû¿ë

Clinical Application of Combined Self-Rating Anxiety Depression Scale

ÀúÀÚ : ±èâ¼ö

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1989  

MinaprineÀÇ ¸»ÃÊ Ç× Äݸ° È¿°ú¿¡ °üÇÑ ¿¬±¸

A Study on the pheripheral Anticholinergic Effect of Minaprine

ÀúÀÚ : ¹Ú¹¬Èñ

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1990  

°Ý¸® ¼ºÀåµÈ »ýÁãÀÇ Çൿ Ư¼º ¹× HaloperidolÀÇ Ä¡·á È¿°ú

Effects of Haloperidol on the activity of isolated-rearing mouse

ÀúÀÚ : À̱¤Çå

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1990  

ÀÚÆóÀå¾Ö¾ÆÀÇ ¿°»öü ÀÌ»ó

Chromosomal Abnormalities in Autistic Children

ÀúÀÚ : Á¤Ã¶È£

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 1991  

³óÃÌ°ÅÁÖ ³×ÆÈÀΰú Çѱ¹ÀÎÀÇ Á¤½Å°Ç°­¿¡ °üÇÑ È¾¹®È­Àû ¿¬±¸

Transcultural Research for Mental Health between the Rural Pepulation of Nepalese and Korean

ÀúÀÚ : ±è¿µ¿í

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1991  

¾ç·Î¿ø ³ëÀΰú Àç°¡ ³ëÀÎÀÇ ºÒ¾È°ú ¿ì¿ï¿¡ °üÇÑ ºñ±³Á¶»ç

Comparison of the Depression and Anxiety between the Elderly in the Home for the Aged and Thoss in the Community

ÀúÀÚ : ¼­È¿¼®

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1992  

Áß±¹°ÅÁÖ Á¶¼±ÀÎÀÇ ºÒ¾È°ú ¿ì¿ï¿¡ °üÇÑ ½ÇÅÂ

Anxiety & Depression of The Korean Residents in China

ÀúÀÚ : »ç°øÁ¤±Ô

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1992  

ºÎ¸ð¿ÍÀÇ Á¶±âºÐ¸®°¡ ¼ºÀÎÀÇ Á¤½ÅÁúȯ ¹ßº´¿¡ ¹ÌÄ¡´Â ¿µÇâ

The Later Influence of Early Parental Separation on Adult Psychiatric Illness

ÀúÀÚ : ±è¾È³ª

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1992  

ÈòÁã¿¡¼­ ToloxatoneÀÌ Tyramine À¯¹ß Ç÷¾Ð»ó½ÂÀÛ¿ë¿¡ ¹ÌÄ¡´Â ¿µÇâ

The Effect of Toloxatone on the Tyramine-induced Hypertension

ÀúÀÚ : ¿ìÀåÈÆ

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1993  

Toloxatone ¹× EthanolÀÌ ÈòÁã Monoamine Oxidase È°¼ºµµ¿¡ ¹ÌÄ¡´Â ¿µÇâ

Effect of Ethanol and Toloxatone on Monoamine Oxidase Activity of Rat

ÀúÀÚ : ÀÌÈñâ

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1994  

Clozapine°ú HaloperidolÀÌ ÈòÁãÀÇ ¹Ì»óÇÇ°¢°ú ÃøÁÂÇÙ¿¡¼­ Proenkephalin, Protachykinin ¹× ProneurotensinÀÇ À¯ÀüÀÚ Ç¥Çö¿¡ ¹ÌÄ¡´Â ¿µÇâ

The Effect of Clozapine and Haloperidol on Gene Expressions of Proenkephalin, Protachykinin and Proneurotensin in Rat Brain

ÀúÀÚ : ÀÓÈ¿´ö

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 1994  

¾Æµ¿±â ¾çÀ°¿¡ ´ëÇÑ ÀνÄÀÌ ¼ºÀα⠻çȸÀû À¯´ë¿¡ ¹ÌÄ¡´Â ¿µÇâ

The Effects of Parenting on Social Bonds of Adulthood

ÀúÀÚ : Àå»ó·Ä

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1995  

ÁÖÀǷ°áÇÌ °úÀ׿Àå¾Ö ¾Æµ¿ Æò°¡ ôµµÀÇ ±³»ç Æò°¡ÆÇ¿¡ ´ëÇÑ ½Å·Úµµ ¹× Ÿ´çµµ ¿¬±¸

ÀÚüÁ¦ÀÛ¿ø¹®

The Study of Reliability and Validity of Attention Deficit Disorder of Attention Deficit Disorder Ecaluation Scale-School Version(ADDES-SV)

ÀúÀÚ : ¹èÁø¿ì

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1997  

½Å°æÈ°¼º steroid°¡ GABAA-benzodiazepine ¼ö¿ëü º¹ÇÕü¿¡ ¹ÌÄ¡´Â ¿µÇâ

ÀÚüÁ¦ÀÛ¿ø¹®

The Effect of Neuroactive Steroids on the GABAA-Benzodiazepine Receptor Complex

ÀúÀÚ : ÀÌÁ¾ÇÐ

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1997  

Çѱ¹Çü ¼Ò¾Æ±â ÁýÁß·Â ¹®Á¦Ã´µµ : ½Å·Úµµ ¹× Ÿ´çµµ ¿¬±¸

ÀÚüÁ¦ÀÛ¿ø¹®

The Development of the Korean Form of Childhood Attention Problem(CAP) Scale : A Study on the Reliability and validity

ÀúÀÚ : ¼­¿Ï¼®

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1997  

È«»ï»çÆ÷´ÑÀÇ Ç×ºÒ¾È È¿°ú

ÀÚüÁ¦ÀÛ¿ø¹®

Anxiolytic Action of Ginseng Total Saponin

ÀúÀÚ : ·ù¼º¹Î

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1997  

ºÒ¾È-½ºÆ®·¹½º ¹ÝÀÀ¿¡¼­ ¸»Ãʼº benzodiazepine ¼ö¿ëüÀÇ ¹Ðµµ º¯È­

ÀÚüÁ¦ÀÛ¿ø¹®

Upregulation of Renal peripheral Benzodiazepine Receptor in the Anxiety-stress Response

ÀúÀÚ : À̱¤Çå

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 1997  

±Þ¼º Stress À¯¹ß ºÒ¾È¹ÝÀÀÀÇ Çؼҿ¡ ´ëÇÑ ½Å°æ±³ ¼¼Æ÷ ¸»Ãʼº Benzodiazepine ¼ö¿ëüÀÇ ¸Å°³ÀÛ¿ë

Glial Peripheral Benzodiazepine Receptor Mediates the Relief of Acute Stress-Induced Anxiety in Rats

ÀúÀÚ : ±è¿µ¿í

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 1998  

¹Ýº¹Àû ½ºÆ®·¹½º°¡ ÈòÁãÀÇ opioid¼º ½Å°æÀü´Þ¿¡ ¹ÌÄ¡´Â ¿µÇâ

Effects of Repeated Stress on the Opioidergic Neurotrnsmission in rats

ÀúÀÚ : »ç°øÁ¤±Ô

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 1998  

¹Ýº¹Àû ½ºÆ®·¹½º°¡ neurosteroidÀÇ GABAA¼ö¿ëü Á¶ÀýÀÛ¿ë¿¡ ¹ÌÄ¡´Â ¿µÇâ

The Effect of Repeated stress on the Modulation of Neuroactive Steroids at the GABAA-Benzodiazepine Receptor Compex

ÀúÀÚ : ÀåºÀ¼®

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1998  

ÈòÁã¿¡¼­ ¹Ýº¹Àû ½ºÆ®·¹½º°¡ GABA¼º ½Å°æÀü´Þ¿¡ ¹ÌÄ¡´Â ¿µÇâ

Effects of Repeated Stress on the GABAergic Neurotransmission in Rats

ÀúÀÚ : ±èâ¼ö

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 1999  

ÁÖÀǷ°áÇÌ°ú °úÀ×ÇൿÀå¾Ö ¾Æµ¿¿¡ À־ÀÇ ¿¬¼Ó¼öÇà°Ë»çÀÇ Áø´ÜÀû À¯¿ë¼º

The Diagnostic Avilabilty of Continuous Performance Test in Children with Attention Deficit Hyperactivity Disorder

ÀúÀÚ : ±¸º»ÈÆ

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1999  

ÁÖÀÇ·Â °áÇÌ °úÀ×ÇൿÀå¾Ö ¾Æµ¿ÀÇ Æò°¡¸¦ À§ÇÑ Á¤Áö½ÅÈ£°úÁ¦ÀÇ Àû¿ë

The Application of Stop-Signal Task for Evaluation of Children with Attention Deficit Hyperactivity Deficit Hyperactivity Disordrt

ÀúÀÚ : ½ÃÇö¼®

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1999  

¹Ýº¹Àû ½ºÆ®·¹½º°¡ ³úÁ¶Á÷ÀÇ Ç×»êÈ­È°¼º¿¡ ¹ÌÄ¡´Â ¿µÇâ

Effect of Repeated Stress on the Antioxidant Activities of Brain

ÀúÀÚ : ¼ÛâÁø

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2000  

ƽ Àå¾Ö¿Í ÁÖÀÇ·Â °áÇÌ °úÀ×ÇൿÀå¾Ö ¾Æµ¿¿¡ À־ÀÇ ½ÇÇà±â´É ºñ±³

The Comparision of The Executive Function Between Children with Tic Disorder and Attention Deficit Hyperactivity Disorder

ÀúÀÚ : ¼ºÇü¸ð

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2000  

ÈòÁãÀÇ ½ºÆ®·¹½º ¹ÝÀÀ¿¡¼­ ³úÁ¶Á÷ÀÇ Ç×»êÈ­È¿¼Ò È°¼ºÀÇ º¯È­

Characteristics of Changes of Antioxidant Activities of Brain in the Stress-Related Responses

ÀúÀÚ : ÀÌÁ¾ÇÐ

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2000  

ÁÖÀǷ°áÇÌ °úÀ×ÇൿÀå¾Ö ¾Æµ¿¿¡¼­ methylphenidate Åõ¿©¿¡ ÀÇÇÑ ¿¬¼Ó¼öÇà°Ë»çÀÇ º¯È­¾ç»ó

The Effects of Methylphenidate on Continuous Performance Test in the Children with Attrntion Deficit Hyperactivity Disorder

ÀúÀÚ : ÀÌÈñÁ¤

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2000  

ÁÖÀÇ·Â °áÇÌ °úÀ×Çൿ Àå¾Ö ¾Æµ¿ÀÇ ¿¬·É¿¡ µû¸¥ Ư¼º ºñ±³

Developmental Changes of Children with Attention Deficit Hyperactivity Disorder

ÀúÀÚ : Á¤¿µÃ¶

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2000  

ÇнÀÀå¾Ö¸¦ µ¿¹ÝÇÑ ÁÖÀǷ°áÇÌ °úÀ×ÇൿÀå¾Ö ¾Æµ¿ÀÇ ÀÓ»óÀû Ư¼º

ÀúÀÚ : ¹Ú¼øÀç

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2001  

ÀμºÀ¯Çü¿¡ µû¸¥ ÁÖÀǷ°áÇÌ°úÀ×ÇൿÀå¾Ö ¾Æµ¿ÀÇ ÀÓ»óÀû ¾ç»ó

ÀúÀÚ : Àå¹ÎÁ¤

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2001  

ÁÖÀǷ°áÇÌ °úÀ×ÇൿÀ» ÁÖ Áõ»óÀ¸·Î ÇÑ ¼Ò¾Æû¼Ò³â ȯÀÚÀÇ ÀÓ»óƯ¼º

»ó¼¼º¸±â

The Clinical Characteristics of Child and Adolescent with Attention Deficit or Hyperactivity

ÀúÀÚ : ¹èÁø¿ì

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2002  

ÁÖÀǷ°áÇÌ °úÀ×ÇൿÀå¾ÖÀÇ ¾ÆÇüº° Ư¼º ºñ±³

»ó¼¼º¸±â

Clinical and Neuropsychological Characteristics of DSM-IV Subtypes of Attention Deficit Hyperactivity Disorder

ÀúÀÚ : ¼­Çؼ÷

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2002  

Ç×¾ÏÁ¦ Åõ¿© ȯÀÚÀÇ ¿ì¿ï ¾ç»ó

»ó¼¼º¸±â

The characteristics of depession in cancer patient on chemotherapy

ÀúÀÚ : ÁÖ ¿­

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2002  

ÁÖÀǷ°áÇÌ °úÀ×ÇൿÀå¾ÖÀÇ Ä¡·áÈ¿°ú ¿¹ÃøÀÎÀÚ

»ó¼¼º¸±â

The Predictive Factors of Treatment Effects in Children with Attention Deficit Hyperactivity Disorder

ÀúÀÚ : ¼ºÇü¸ð

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2002  

SwansonÀÇ ÁÖÀǷ°áÇÌ Àå¾ÖôµµÀÇ Çѱ¹ÆÇ Ç¥ÁØÈ­

»ó¼¼º¸±â

The Study of Standardization of Swanson's Attention Defict Disorder Scale in Korean version

ÀúÀÚ : ¹Ú¼ºÂù

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2002  

ÁÖÀǷ°áÇÌ°úÀ×ÇൿÀå¾Ö ¾Æµ¿ÀÇ ÁöÀû¼öÁØÀÌ ÇൿÁõ»ó°ú ½ÇÇà±â´É¿¡ ¹ÌÄ¡´Â ¿µÇâ

»ó¼¼º¸±â

The Effects of Intellectual Level on Behavioral Symptoms and Executive Functions in Children with ADHD

ÀúÀÚ : õÀºÁø

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2003  

³ë³â±â ¿µ¼º°ú ºÒ¾È ¿ì¿ï ¹× »îÀÇ Áú°úÀÇ °ü°è

»ó¼¼º¸±â

The relationship of spiritual well-being and anxiety, depression and quality of life in active old age

ÀúÀÚ : ¿°Çü¿í

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2003  

½Å°æÀÎÁö ¹× Àμº °Ë»ç¸¦ ÅëÇÑ ¿Ü»ó¼º ³ú¼Õ»óȯÀÚÀÇ ÀÓ»ó¾ç»ó

»ó¼¼º¸±â

Clinical characteristics of patients with traumatic brain injury in neuropsychological tests and MMPI

ÀúÀÚ : Á¤ÀºÁ¤

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2004  

ÁÖÀǷ°áÇÌ °úÀ×ÇൿÀå¾ÖÀÇ Çѱ¹ÆÇ Æò°¡Ã´µµ °³¹ß

»ó¼¼º¸±â

The Development of Korean Attention Deficit Hyperactivity Disorder Scale

ÀúÀÚ : ¼ÛâÁø

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2005  

ADHD ¾Æµ¿ÀÇ ÀÎÁöó¸® À¯Çü Ư¼º

»ó¼¼º¸±â

The Characteristic of Cognitive Processing in Children with ADHD

ÀúÀÚ : ÀÌÇý¸°

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2006  

Á¤½ÅºÐ¿­º´ ȯÀÚ¿¡¼­ ¿ì¿ïÆò°¡Ã´µµÀÇ À¯¿ë¼º

»ó¼¼º¸±â

Efficacy of Depression Rating Scales in Schizophrenic Patients

ÀúÀÚ : ·ùÁö¾È

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2007  

Á¤½ÅºÐ¿­º´ ȯÀÚ¿¡¼­ Áö´É ÀúÇÏ ¼öÁØ°ú Á¤½Åº´¸®¿ÍÀÇ °ü°è

»ó¼¼º¸±â

The Relationship Between Intelligence Decline and Psychopathology in Schizophrenic Patients

ÀúÀÚ : ¹èÁØ¿ë

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2007  

SwansonÀÇ ÁÖÀǷ°áÇÌ Àå¾Öôµµ¥³ÀÇ Çѱ¹ÆÇ Ç¥ÁØÈ­

»ó¼¼º¸±â

The Standardization of SNAP-IV in Korean version

ÀúÀÚ : ÀåÇý°æ

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2007  

¿Ü»ó¼º Ä¡¸ÅÀÇ ½Å°æÀÎÁö Ư¼º

»ó¼¼º¸±â

Neurocognitive Characteristics of the Dementia

ÀúÀÚ : ±è¾È³ª

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2008  

º´»ç¿ë Áø´Ü¼­¸¦ ¹ß±Þ¹ÞÀº Á¤½Å°ú ȯÀÚÀÇ Á¤½Åº´¸®

»ó¼¼º¸±â

Psychopathology of Psychiatric Patients with Medical Certification for Military

ÀúÀÚ : ¹Ú»óÁØ

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2008  

Á¤½ÅºÐ¿­º´ ȯÀÚÀÇ ¿ì¿ïÁõ»ó¿¡ ¹ÌÄ¡´Â ¿äÀÎ

»ó¼¼º¸±â

Factors Affecting Depression of the Schizophrenic Patients

ÀúÀÚ : õÀºÁø

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2008  

ADHDÀÇ Á¤½Åº´¸®¿¡ µû¸¥ ½Å°æÀÎÁö±â´É

»ó¼¼º¸±â

Neurocognitive function and psychopathology in children with ADHD

ÀúÀÚ : Á¤¿µÃ¶

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2008  

´ë±¸ ½Ã³» ÃʵîÇлýÀÇ ¼ö¸é¾ç»ó

»ó¼¼º¸±â

Sleep problems in elementary schoolchildren

ÀúÀÚ : ±è¹ÎÁö

Àü°ø : Á¤½Å°Ç°­ÀÇÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2009  

¿Ü»ó¼º ³ú¼Õ»ó ȯÀÚÀÇ ½Å°æÀÎÁö±â´É°ú Á¤½Åº´¸®

»ó¼¼º¸±â

Neurocognitive function and psychopathology of patients with traumatic brain injury

ÀúÀÚ : ÁÖ ¿­

Àü°ø : Á¤½Å°Ç°­ÀÇÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2009  

ÁÖ°üÀû ±â¾ï·Â ÀúÇϸ¦ È£¼ÒÇÏ´Â ³ëÀΠȯÀÚÀÇ ÀÎÁö±â´É ¾ç»ó

»ó¼¼º¸±â

Manifestation of congnitive function in geriatric patient with subjective memory complaint

ÀúÀÚ : ¹ÚÇÑ°á

Àü°ø : Á¤½Å°Ç°­ÀÇÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2010  

¾ËÂêÇÏÀ̸ÓÇü Ä¡¸Å¿¡¼­ Çѱ¹ÆÇ º¸½ºÅæ À̸§ ´ë±â °Ë»ç¿Í Áö¿¬ ȸ»ó °Ë»çÀÇ Áø´ÜÀû À¯¿ë¼º

»ó¼¼º¸±â

Clinical usefulness of Korean Boston Naming Test and Delayed Recall Test in diagnosing dementia of the Alzheimer's type

ÀúÀÚ : ÀÌÁØ¿±

Àü°ø : Á¤½Å°Ç°­ÀÇÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2010  

ADHDÀÇ ÇൿÁõ»ó À¯Çü¿¡ µû¸¥ Á¤½Åº´¸® ¹× ÀÎÁö±â´É

»ó¼¼º¸±â

Psychopathology and Neurocognitive Function

ÀúÀÚ : ÀÌÇý¸°

Àü°ø : Á¤½Å°Ç°­ÀÇÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2010  

MMPI-¥±ÀÇ 8°³ Ÿ´çµµ ôµµÀÇ ÀÓ»óÀû À¯¿ë¼º

»ó¼¼º¸±â

Clinical value of 8 validity subscales of MMPI-¥±

ÀúÀÚ : ±è°æ±Ù

Àü°ø : Á¤½Å°Ç°­ÀÇÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2010  

ÁÖÀǷ°áÇÌ °úÀ×ÇൿÀå¾Ö ¾Æµ¿ÀÇ ¾ð¾î±â¾ï´É·Â¿¡ ´ëÇÑ ´Ù¸¥ ½Å°æÀÎÁö±â´ÉÀÇ ¿µÇâ

»ó¼¼º¸±â

Effects of other neurocognitive functions to verbal memory ability in children with attention deficit hyperactivity disorder

ÀúÀÚ : Â÷ ¿µ

Àü°ø : Á¤½Å°Ç°­ÀÇÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2011  

°æµµ ¿Ü»ó¼º ³ú ¼Õ»ó ȯÀÚÀÇ Á¤½Å°úÀû Áõ»ó À¯Çü¿¡ µû¸¥ ½Å°æÀÎÁö ±â´É

»ó¼¼º¸±â

Neurocognitive function by psychiatric symptom profile in patients with mild traumatic brain injury

ÀúÀÚ : ±è¼ø¼·

Àü°ø : Á¤½Å°Ç°­ÀÇÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2011  

¼ö¸é´Ù¿ø°Ë»ç¸¦ ÀÌ¿ëÇÑ ±â¸éº´ ȯÀÚÀÇ ³úÆÄ ½ºÆåÆ®·³ ºÐ¼®

»ó¼¼º¸±â

Electroencephalographic Spectral Analysis in Narcoleptic Patient by Polysomnography

ÀúÀÚ : ÃÖÈ£µ¿

Àü°ø : Á¤½Å°Ç°­ÀÇÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2012  

ÀΰÝÀå¾ÖÀÇ Á¤½Åº´¸® ¹× ¹æ¾î±âÁ¦

»ó¼¼º¸±â

Psychopathologies and defense mechanisms of personality disorders

ÀúÀÚ : Á¤Áø¿µ

Àü°ø : Á¤½Å°Ç°­ÀÇÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2013  

Ä¡·áÀúÇ×¼º ¶Ñ·¿Àå¾Ö¸¦ °¡Áø ¼Ò¾Æû¼Ò³â¿¡¼­ °æµÎ°³ÀÚ±âÀڱؼúÀÇ È¿¿ë¼º°ú ¾ÈÀü¼º

»ó¼¼º¸±â

Efficacy and Safety of Repetitive Transcranial Magnetic Stimulation on Supplementary Motor Area in the Children and Adolescents with Treatment-Resistant Tourette Syndrome

ÀúÀÚ : äÁøÇõ

Àü°ø : Á¤½Å°Ç°­ÀÇÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2015  

´º·ÎÇǵå¹éÀÌ ÁÖ¿ä¿ì¿ïÀå¾ÖÀÇ ±â´Éȸº¹ ¹× »ýüÁöÇ¥¿¡ ¹ÌÄ¡´Â ¿µÇâ

»ó¼¼º¸±â

Neurofeedback treatment on functional recovery and biological marker in major depressive disorder

ÀúÀÚ : ÀÌ°¡¿ø

Àü°ø : Á¤½Å°Ç°­ÀÇÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2016  

´º·ÎÇǵå¹é alpha/theta ÈÆ·Ã ÀüÈÄÀÇ Á¤·®È­ ³úÆÄ ºÐ¼®

»ó¼¼º¸±â

The Analyses of QEEG Changes Before and After Neurofeedback Alpha/Theta Training

ÀúÀÚ : ÀÌ¿µÁö

Àü°ø : Á¤½Å°Ç°­ÀÇÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2016  

Ä¡¸ÅÀÇ ¾ÆÇü¿¡ µû¸¥ ½Å°æÀÎÁö±â´ÉÀÇ Æ¯¼º ¹× ÁßÁõµµ¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÀÎÁöÀû ¿äÀÎ

»ó¼¼º¸±â

Characteristics of Cognitive function by the type of Neurocognitive disorder and Cognitive factors affecting severity classification of Neurocognitive disorder

ÀúÀÚ : À̽¿ì

Àü°ø : Á¤½Å°Ç°­ÀÇÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2016  

³ëÀμº ¿ì¿ïÁõ¿¡¼­ ³ú ¾Æ¹Ð·ÎÀ̵å ħÂø°ú ÀÎÁö ±â´ÉÀÇ º¯È­

»ó¼¼º¸±â

Cerebral amyloid deposition and the changes in cognitive functions in geriatric depression

ÀúÀÚ : ±èÇý±Ý

Àü°ø : Á¤½Å°Ç°­ÀÇÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2017  

ÀÚÆóÁõ ÀÚ³à ¾î¸Ó´ÏÀÇ ¾çÀ° ½ºÆ®·¹½º¿Í »îÀÇ Áú

»ó¼¼º¸±â

Parenting stress and life quality of autism patient's mother

ÀúÀÚ : À±¼®È£

Àü°ø : Á¤½Å°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2017  

ÀÚ»ì ½Ãµµ À¯¹«¿¡ µû¸¥ °æ°è¼º ¼º°ÝÀå¾Ö ȯÀÚÀÇ ½É¸® Ư¼º

»ó¼¼º¸±â

Psychological characteristics according to suicide attempt in patients with borderline personality disorder

ÀúÀÚ : ±Ý¹«¼º

Àü°ø : Á¤½Å°Ç°­ÀÇÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2018  

ÁÖ¿ä¿ì¿ïÀå¾Ö ȯÀÚÀÇ ±âÁú ¹× ½É¸® Ư¼º : ¿Ü»ó ¹× ½ºÆ®·¹½º °ü·Ã Àå¾Ö¿Í ºñ±³

»ó¼¼º¸±â

Temperament and psychological characteristics of patients with major depressive disorder : Compared with patients with trauma and stress-related disorders

ÀúÀÚ : Á¶¼ÒÇý

Àü°ø : Á¤½Å°Ç°­ÀÇÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2018  

Çѱ¹ÀÇ ÁÖÀǷ°áÇÌ/°úÀ×ÇൿÀå¾Ö ¼Ò¾Æû¼Ò³â¿¡¼­ ¸ÞÆ¿Æä´Ïµ¥ÀÌÆ®°¡ ¼ºÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ

»ó¼¼º¸±â

Effects of Methylphenidate on Growth of Children and Adolescents with Attention Deficit/Hyperactivity Disorders in South Korea

ÀúÀÚ : °ø³ª¿µ

Àü°ø : Á¤½Å°Ç°­ÀÇÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2020  

¿ì¿ïÀå¾Ö ȯÀÚÀÇ ±âÁú ¹× ¹æ¾î±âÁ¦ ¾ç»ó: ºÒ¾È Áõ»óÀÇ µ¿¹Ý À¯¹«¿¡ µû¸¥ ºñ±³

»ó¼¼º¸±â

Temperament and Defense Mechanism Patterns of Patients with Depressive Disorder: In Comparison with or without Anxiety Symptom

ÀúÀÚ : ±èÁø¿ì

Àü°ø : Á¤½Å°Ç°­ÀÇÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2020